Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease.

Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease.

Item
http://www.wikidata.org/entity/Q40390092
Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Infliximab treatment for refractory kawasaki disease in korean children.Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmasCirculating angiogenic cell function is inhibited by cortisol in vitro and associated with psychological stress and cortisol in vivoComorbidity of Kawasaki disease and group a streptococcal pleural effusion in a healthy child: a case report.Epidemiology and management of Kawasaki disease.Management of acute and refractory Kawasaki disease.An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.Treatment Options for Resistant Kawasaki Disease.Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).TNF-α blockers for the treatment of Kawasaki disease in children
P2860

Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease.

Item
http://www.wikidata.org/entity/Q40390092
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Infliximab reduces the cytokin ...... n refractory Kawasaki disease.
@en
type
label
Infliximab reduces the cytokin ...... n refractory Kawasaki disease.
@en
prefLabel
Infliximab reduces the cytokin ...... n refractory Kawasaki disease.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Infliximab reduces the cytokin ...... n refractory Kawasaki disease.
@en
P2093
P2860
P2888
P304
P31
P356
10.1203/PDR.0B013E31819ED68D
P407
P433
P478
P577
P6179
P698
P921